23 results
424B5
IKNA
Ikena Oncology Inc
12 Sep 23
Prospectus supplement for primary offering
4:11pm
from our public offerings;
developments relating to our competitors and our industry;
the effect of the COVID-19 pandemic, or a similar pandemic
424B5
cvx5yjtrdk58oxa7fcu
15 May 23
Prospectus supplement for primary offering
7:27am
S-3
aro eccttvs8fpp
27 Apr 22
Shelf registration
5:17pm
DEF 14A
v8erc
27 Apr 22
Definitive proxy
4:32pm
10-K
7m8f5
17 Mar 22
Annual report
6:31am
8-K
EX-99.1
yxwq7nh 7t1s
10 Nov 21
Regulation FD Disclosure
4:39pm
10-Q
fneg by6e
13 May 21
Quarterly report
4:15pm
424B4
m1wroie
26 Mar 21
Prospectus supplement with pricing info
5:04pm
S-1/A
ci2wdkv
22 Mar 21
IPO registration (amended)
8:51am
CORRESP
k49q6t33gnz6s
12 Mar 21
Correspondence with SEC
12:00am